Midazolam Minimally Impairs Thermoregulatory Control
- 1 August 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 81 (2) , 393-398
- https://doi.org/10.1097/00000539-199508000-00032
Abstract
Perioperative hypothermia usually results largely from pharmacologic inhibition of normal thermoregulatory control.Midazolam is a commonly used sedative and anesthetic adjuvant whose thermoregulatory effects are unknown. We therefore tested the hypothesis that midazolam administration impairs thermoregulatory control. Eight volunteers were studied on 2 days each, once without drug and once at a target total plasma midazolam concentration of 0.3 micro gram/mL (corresponding to administration of approximate equals 40 mg over approximate equals 4 h). Each day, skin and core temperatures were increased sufficiently to provoke sweating, and then reduced to elicit peripheral vasoconstriction and shivering. We mathematically compensated for changes in skin temperature using the established linear cutaneous contributions to control of each response. From these calculated thresholds (core temperatures triggering responses at a designated skin temperature of 34 degrees C), we determined the thermoregulatory effects of midazolam. The sweating threshold was decreased approximate equals 0.3 degrees C by midazolam administration: 37.3 +/- 0.2 degrees C vs 37.0 +/- 0.3 degrees C (P = 0.0004, paired t-test). Midazolam decreased the core temperature that triggered vasoconstriction somewhat more: 37.1 +/- 0.2 degrees C vs 36.3 +/- 0.5 degrees C (P = 0.0002). Similarly, midazolam decreased the shivering threshold: 35.9 +/- 0.3 degrees C vs 35.3 +/- 0.6 degrees C (P = 0.03). The sweating-to-vasoconstriction (interthreshold) range, therefore, increased from 0.2 +/- 0.1 degrees C to 0.7 +/- 0.3 degrees C (P = 0.002). Although statistically significant, this relatively small increase contrasts markedly with the 3-5 degrees C interthreshold ranges produced by clinical doses of volatile anesthetics, propofol, and opioids. Thus, plasma concentrations of midazolam far exceeding those used routinely produce relatively little impairment of thermoregulatory control. (Anesth Analg 1995;81:393-8)Keywords
This publication has 31 references indexed in Scilit:
- Propofol Linearly Reduces the Vasoconstriction and Shivering ThresholdsAnesthesiology, 1995
- Propofol Causes a Dose-dependent Decrease in the Thermoregulatory Threshold for Vasoconstriction but Has Little Effect on SweatingAnesthesiology, 1994
- Mild hypothermia during isoflurane anesthesia decreases resistance to E. coli dermal infection in guinea pigsActa Anaesthesiologica Scandinavica, 1994
- Rate and Gender Dependence of the Sweating, Vasoconstriction, and Shivering Thresholds in HumansAnesthesiology, 1994
- Physiologic Responses to Hyperthermia during Epidural Anesthesia and Combined Epidural/Enflurane Anesthesia in WomenAnesthesiology, 1993
- Unintentional Hypothermia Is Associated with Postoperative Myocardial IschemiaAnesthesiology, 1993
- Thermoregulatory responses to hyperthermia during isoflurane anesthesia in humansJournal of Applied Physiology, 1993
- Epidural versus General Anesthesia, Ambient Operating Room Temperature, and Patient Age as Predictors of Inadvertent HypothermiaAnesthesiology, 1992
- Painful Stimulation Minimally Increases the Thermoregulatory Threshold for Vasoconstriction during Enflurane Anesthesia in HumansAnesthesiology, 1992
- The Thermoregulatory Threshold is Inversely Proportional to Isoflurane ConcentrationAnesthesiology, 1990